Oisín raised $9.5M to advance senolytic therapies for kidney & age-related diseases
Longevity Technology - 28-May-2021Investigational therapy on old mice cleared senescent cells up to 70%, extending life by 20%
Join the club for FREE to access the whole archive and other member benefits.
Executive Chairman and co-founder of Oisín Biotechnologies
Gary Hudson is Executive Chairman and co-founder of Oisín Biotechnologies. Mr. Hudson is also active in several non-profits focusing on age-related disease. He provided seed funding for the SENS Research Foundation which is transforming the way the world researches and treats age-related disease. He is a major donor to and serves as an advisor to the Methuselah Foundation, dedicated to extending the healthy human lifespan by advancing tissue engineering and regenerative medicine therapies.
Prior to Oisin, Mr. Hudson has worked extensively in the field of commercial space successfully starting and growing several companies. He is best known as the founder of Rotary Rocket, which built a landing test simulator for a reusable rocket that flew three successful flights in 1999. He has won several awards during his career including Laurel Award from Aviation Week and Space Technology, the Founder’s Award from the Space Frontier Foundation and was inducted into the International Space Hall of Fame in 2014 for his contributions to the field. Mr. Hudson currently is the President of the Space Studies Institute, a non-profit dedicated to commercial space flight and human space travel.
Visit website: https://www.oisinbio.com/#the-team/#gary
See also: Oisin Biotechnologies - Drug development company focused on the senolytic technology to fight age-related diseases
Details last updated 27-Dec-2019
Investigational therapy on old mice cleared senescent cells up to 70%, extending life by 20%
Allowing developments on tech that will kill cancer based on their genetics
Turn.bio testing new in vivo therapy - good results for sarcopenia in mice